Song, Yongfeng
Tran, Melanie
Wang, Li
Shin, Dong-Ju
Wu, Jianguo http://orcid.org/0000-0001-9801-5267
Funding for this research was provided by:
American Heart Association (18POST33960183)
U.S. Department of Health & Human Services | NIH | National Institute on Alcohol Abuse and Alcoholism (NIH R01AA026322, P50AA024333, R01AA027456, U01AA026938, K01AA029474)
U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (P30DK097948)
U.S. Department of Health & Human Services | NIH | National Institute on Alcohol Abuse and Alcoholism
U.S. Department of Health & Human Services | NIH | National Institute on Alcohol Abuse and Alcoholism
U.S. Department of Health & Human Services | NIH | National Institute on Alcohol Abuse and Alcoholism
U.S. Department of Health & Human Services | NIH | National Institute on Alcohol Abuse and Alcoholism
This article is maintained by: Elsevier
Article Title: MiR-200c-3p targets SESN1 and represses the IL-6/AKT loop to prevent cholangiocyte activation and cholestatic liver fibrosis
Journal Title: Laboratory Investigation
CrossRef DOI link to publisher maintained version: https://doi.org/10.1038/s41374-021-00710-6
Content Type: article
Copyright: © 2021 The Authors.